Sheele JM, Morris N, Byars D, Counselman F. Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department.
Indian J Sex Transm Dis AIDS 2017. [PMID:
28442805 PMCID:
PMC5389217 DOI:
10.4103/2589-0557.203438]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
BACKGROUND
Proton pump inhibitors (PPIs) have been shown in cell culture to kill Trichomonas vaginalis (TV) at lower half maximal inhibitory concentration values than metronidazole (Flagyl), the most common medication used to treat the infection. However, there have been no previous clinical investigations to determine if PPIs are associated with reduced risk for TV.
MATERIALS AND METHODS
We examined the records of female patients who received testing in the emergency department for TV, Neisseria gonorrhoea (GC), and Chlamydia trachomatis (CT) between 2010 and 2014 at two academic medical centers to determine if PPI and histamine type 2 receptor antagonist (H2RA) drugs were associated with TV and GC/CT infections.
RESULTS
We found that H2RAs were associated with an increased likelihood for TV (odds ratio [OR]: 2.0, P < 0.0001) and GC and/or CT infections (OR: 1.49, P < 0.0001). PPIs were associated with a reduced likelihood for TV (OR: 0.75, P < 0.0001) and GC and/or CT infections (OR: 0.57, P < 0.0001). In patients infected with GC and/or CT, the likelihood of coinfection with TV was reduced in those taking a PPI (OR: 0.64, P = 0.054) and increased in those taking an H2RA (OR: 1.62, P = 0.003).
CONCLUSIONS
PPIs are associated with a reduced risk for TV and GC/CT infection.
Collapse